Sormani MP, Häring DA, Kropshofer H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, 277.
MR CLEAN studie wint Wetenschaps- en Innovatieprijs 2017
mrt 2017 | Neuro-vasculair